By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

InVivoScribe Technologies, Inc. 

6330 Nancy Ridge Drive
Suite 106
San Diego  California  92121-3230  U.S.A.
Phone: 858-623-8105 Fax: 858-623-8109


SEARCH JOBS


Industry
Diagnostics






Company News
InVivoScribe Technologies, Inc. Receives FDA Approval For The Leukostrat Cdx FLT3 Mutation Assay Companion Diagnostic Test For The Selection Of Patients For Rydapt And Is The First Companion Diagnostic For AML 4/28/2017 11:12:03 AM
InVivoScribe Technologies, Inc. Expands Ion PGM NGS Platform Menu: Releases Additional CE-IVD Clonality Kits With Bioinformatics Software And RUO Kits With MRD Software 2/28/2017 11:02:28 AM
InVivoScribe Technologies, Inc. Announces Long-Term Collaboration Agreement With Illumina (ILMN) And Plans Release Of NGS-based IVD Assay Kits 2/14/2017 12:04:38 PM
InVivoScribe Technologies, Inc. Release: German Supreme Court Upholds And Strengthens Invivoscribe FLT3 Patent Position 3/30/2016 10:27:04 AM
InVivoScribe Technologies, Inc. Announces Long-Term Collaboration To Develop Immuno-Oncology Tests With Thermo Fisher Scientific (TMO) 2/11/2016 10:37:25 AM
InVivoScribe Technologies, Inc. Announces Companion Diagnostic Agreement 4/28/2015 11:18:35 AM
InVivoScribe Technologies, Inc. Launches Four CE-Marked NGS-Based LymphoTrack Dx Assays 4/21/2015 12:19:20 PM
InVivoScribe Technologies, Inc. Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu 12/6/2012 9:43:15 AM
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan 12/5/2012 9:56:58 AM
InVivoScribe Technologies, Inc. Announces Collaboration Agreement to Develop Companion Diagnostic Test 2/16/2011 8:32:31 AM
12
//-->